Literature DB >> 3134289

Arabinofuranosyl nucleosides induce common fragile sites.

J C Leonard1, R C Leonard, K H Thompson.   

Abstract

The capacities for fragile site induction of three inhibitors of semiconservative DNA synthesis and DNA repair synthesis, aphidicolin, arabinofuranosyl cytosine, and arabinofuranosyl adenosine were compared. Aphidicolin is known to induce type 4 fragile sites, the largest recognized group of common fragile sites. Although the modes of action of these inhibitors vary, both arabinofuranosyl analogs induce type 4 aphidicolin-sensitive fragile sites. An analysis of variance demonstrates that the three inhibitors are not equally capable of inducing significant breakage (P less than 0.01) at all type 4 fragile sites. Induction of type 4 fragile sites appears to be a general consequence of inhibition of DNA polymerization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134289     DOI: 10.1007/bf00280556

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells.

Authors:  D S Shewach; W Plunkett
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha.

Authors:  S Ikegami; T Taguchi; M Ohashi; M Oguro; H Nagano; Y Mano
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

3.  Aphidicolin inhibits eukaryotic DNA replication and repair --- implications for involvement of DNA polymerase alpha in both processes.

Authors:  N A Berger; K K Kurohara; S J Petzold; G W Sikorski
Journal:  Biochem Biophys Res Commun       Date:  1979-07-12       Impact factor: 3.575

4.  DNA replication and UV-induced DNA repair synthesis in human fibroblasts are much less sensitive than DNA polymerase alpha to inhibition by butylphenyl-deoxyguanosine triphosphate.

Authors:  S L Dresler; M G Frattini
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

5.  DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.

Authors:  T W Glover; C Berger; J Coyle; B Echo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Constitutive fragile sites and cancer.

Authors:  J J Yunis; A L Soreng
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

7.  Purification and characterization of two new high molecular weight forms of DNA polymerase delta.

Authors:  J J Crute; A F Wahl; R A Bambara
Journal:  Biochemistry       Date:  1986-01-14       Impact factor: 3.162

8.  Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.

Authors:  D W Kufe; P P Major; D Munroe; M Egan; D Herrick
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

9.  Arrest of chain growth of replicon-sized intermediates by aphidicolin during rat fibroblast cell chromosome replication.

Authors:  T Yagura; T Kozu; T Seno
Journal:  Eur J Biochem       Date:  1982-03

10.  Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates.

Authors:  U Lönn; S Lönn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

View more
  1 in total

1.  Cell type-dependent difference in the distribution and frequency of aphidicolin-induced fragile sites: T and B lymphocytes and bone marrow cells.

Authors:  I Murano; A Kuwano; T Kajii
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.